Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 3
2008 2
2009 2
2010 2
2011 2
2012 5
2013 5
2014 4
2015 2
2016 3
2017 3
2018 4
2020 2
2021 5
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Synergistic induction of blood-brain barrier properties.
Porkoláb G, Mészáros M, Szecskó A, Vigh JP, Walter FR, Figueiredo R, Kálomista I, Hoyk Z, Vizsnyiczai G, Gróf I, Jan JS, Gosselet F, Pirity MK, Vastag M, Hudson N, Campbell M, Veszelka S, Deli MA. Porkoláb G, et al. Among authors: veszelka s. Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2316006121. doi: 10.1073/pnas.2316006121. Epub 2024 May 15. Proc Natl Acad Sci U S A. 2024. PMID: 38748577
Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.
Mészáros M, Phan THM, Vigh JP, Porkoláb G, Kocsis A, Páli EK, Polgár TF, Walter FR, Bolognin S, Schwamborn JC, Jan JS, Deli MA, Veszelka S. Mészáros M, et al. Among authors: veszelka s. Cells. 2023 Feb 3;12(3):503. doi: 10.3390/cells12030503. Cells. 2023. PMID: 36766845 Free PMC article.
Soluplus® promotes efficient transport of meloxicam to the central nervous system via nasal administration.
Sipos B, Bella Z, Gróf I, Veszelka S, Deli MA, Szűcs KF, Sztojkov-Ivanov A, Ducza E, Gáspár R, Kecskeméti G, Janáky T, Volk B, Budai-Szűcs M, Ambrus R, Szabó-Révész P, Csóka I, Katona G. Sipos B, et al. Among authors: veszelka s. Int J Pharm. 2023 Feb 5;632:122594. doi: 10.1016/j.ijpharm.2023.122594. Epub 2023 Jan 7. Int J Pharm. 2023. PMID: 36626972
Blood-brain barrier dysfunction in L-ornithine induced acute pancreatitis in rats and the direct effect of L-ornithine on cultured brain endothelial cells.
Walter FR, Harazin A, Tóth AE, Veszelka S, Santa-Maria AR, Barna L, Kincses A, Biczó G, Balla Z, Kui B, Maléth J, Cervenak L, Tubak V, Kittel Á, Rakonczay Z Jr, Deli MA. Walter FR, et al. Among authors: veszelka s. Fluids Barriers CNS. 2022 Feb 17;19(1):16. doi: 10.1186/s12987-022-00308-0. Fluids Barriers CNS. 2022. PMID: 35177109 Free PMC article.
A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.
Veszelka S, Mészáros M, Porkoláb G, Szecskó A, Kondor N, Ferenc G, Polgár TF, Katona G, Kóta Z, Kelemen L, Páli T, Vigh JP, Walter FR, Bolognin S, Schwamborn JC, Jan JS, Deli MA. Veszelka S, et al. Pharmaceutics. 2021 Dec 30;14(1):86. doi: 10.3390/pharmaceutics14010086. Pharmaceutics. 2021. PMID: 35056983 Free PMC article.
47 results